Evidence map›Paper›PMID 30353651›Full record

ArticleCytometry. Part B, Clinical cytometry2019

A reproducible strategy for analysis of minimal residual disease measured by Standardized multiparametric flow cytometry in b acute lymphoblastic leukemia.

Hector Sarmiento Palao, Fabián Tarín, Fernanda Martirena, Eva Barragán, Esperanza Such, Amparo Sempere, Maria Tasso, Pablo Manresa, Francisco López

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Cytometry. Part B, Clinical cytometry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Hector Sarmiento PalaoDepartment of Hematology, Hospital General Universitari d'Alacant.ORCID 0000-0003-4094-472X
Fabián TarínDepartment of Hematology, Hospital General Universitari d'Alacant.
Fernanda MartirenaDepartment of Hematology, Hospital General de Elda.
Eva BarragánDepartment of Hematology, Hospital Universitario La Fe de Valencia.
Esperanza SuchDepartment of Hematology, Hospital Universitario La Fe de Valencia.
Amparo SempereDepartment of Hematology, Hospital Universitario La Fe de Valencia.
Maria TassoDepartment of Pediatrics, Hospital General Universitari d'Alacant.
Pablo ManresaDepartment of Hematology, Hospital General Universitari d'Alacant.
Francisco LópezDepartment of Hematology, Hospital General Universitari d'Alacant.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Burkitt LymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaB-LymphocytesFlow CytometryHumansNeoplasm, Residual

Identifiers

PMID30353651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.